In recent years, there has been growing interest in vaccination against human papillomavirus (HPV) not only among adolescents, but also among adult women who have not been vaccinated before. Increasingly, patients over the age of 30 are asking their doctors about the appropriateness of vaccination in this age group. Current research and recommendations show that HPV vaccination can also have measurable benefits after the age of 30.